Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2016-07-28 | David W. Anderson 63 Director...Mr. Anderson was appointed to the Board of Directors on February 26, 2016...The Governance and Nomination Committee currently consists of Messrs. Manko (chair), Brad Sealfon, Pastreich, Anderson and Radin...2016 Fiscal Year Director Compensation Table shows David W. Anderson total $0. |
| 2018-03-13 | The Governance and Nomination Committee currently consists of Messrs. Manko (chair), Brad Sealfon, Pastreich, Anderson and Radin. 2017 FISCAL YEAR DIRECTOR COMPENSATION TABLE David W. Anderson Fees Earned or Paid in Cash ($): 10,417 Stock Awards ($): 10,417 Total ($): 20,834 |
| 2019-03-08 | David W. Anderson, Director since 2016. Serves on Audit Committee and Nominating and Corporate Governance Committee. 2018 Director compensation total $25,000. |
| 2020-03-06 | Mr. Anderson has been in the medical (device) industry for over 23 years and since 2017 has served as the Chief Executive Officer for Brain Temp, Inc. Previously, he held the role of Chief Executive Officer for Orteq Sports Medicine from 2014 to 2017 and Gentis, Inc. from 2004 through 2014. He also serves on the board for ACell Inc., (Regenerative Medicine for Woundcare), as well as serves on several advisory committees. Mr. Anderson received a B.S. in Chemical Engineering from Cornell University and attended University of Minnesota for Graduate Studies in Microbiology. The Audit Committee is currently comprised of Messrs. Anderson (chair), Allen and Fletcher and Ms. Frommer. The 2019 fiscal year director compensation table shows David W. Anderson with total compensation of $56,512. |
| 2021-04-05 | Mr. Anderson has been in the medical (device) industry for over 23 years and since 2017 has served as the Chief Executive Officer for Brain Temp, Inc. Previously, he held the role of Chief Executive Officer for Orteq Sports Medicine from 2014 to 2017 and Gentis, Inc. from 2004 through 2014. He also serves on the board for Carmell Therapeutics (Private) (Biologic Bone Repair Materials) , as well as serves on several advisory committees. Mr. Anderson received a B.S. in Chemical Engineering from Cornell University and attended University of Minnesota for Graduate Studies in Microbiology. The Audit Committee is currently comprised of Messrs. Anderson (chair), Allen and Fletcher and Ms. Frommer. Each member of this committee is “independent” within the meaning of applicable SEC rules and standards of the Nasdaq Stock Market LLC (the “Nasdaq”). The Board of Directors has designated Mr. Anderson as the audit committee financial expert, as currently defined under the SEC rules. The Audit Committee held six meetings including two special meetings in connection with meetings of the full Board during the fiscal year ended December 31, 2020. 2020 FISCAL YEAR DIRECTOR COMPENSATION TABLE: David W. Anderson Fees Earned or Paid in Cash ($) 30,000 Stock Awards ($) 30,000 All Other Compensation ($) — Total ($) 60,000. |
Data sourced from SEC filings. Last updated: 2025-08-30